Livongo Health, a consumer digital health company empowering people with chronic conditions to live better and healthier lives, today announced that it will be the first comprehensive offering for people with diabetes to integrate continuous glucose data from Abbott’s FreeStyle® Libre Pro System, a revolutionary continuous glucose monitoring (CGM) system for healthcare professionals.Through this integration collaboration, Livongo will offer, where appropriate and prescribed, the FreeStyle Libre
Read More
New Study Reveals Personalization is Key to Diabetes Management
New study led by Livongo demonstrates that personalization is key to diabetes management and short periods of intensive coaching when people get stuck on their way to their glucose and weight goals can be helpful. A new study reveals that use of Livongo for Diabetes significantly improves the health of people with type 2 diabetes (T2D), according to recent findings reported in the Journal of Diabetes Research. Researchers also found pairing participation in Livongo for Diabetes with lifestyle
Read More
AHRQ Report: Mobile Apps Have Little Clinical Evidence of Improving Diabetes for Patients
A new report by the Agency for Healthcare Research and Quality (AHRQ) on mobile phone applications for diabetes patients reveals that out of hundreds of commercially available apps, only 11 had been researched, and of these, only five were associated with clinically significant improvements in levels of blood sugar control as measured by hemoglobin A1c (HbA1c) tests.Report OverviewAHRQ-funded researchers sought to understand the effectiveness of roughly 280 apps that may be used to support
Read More
Smart Meter’s Diabetes Care Solution Meets Newly Created Remote Monitoring CPT Code
Smart Meter, an innovative diabetes management data, technology and solutions company, today announced that its iGlucose® Diabetes Care Solution meets the requirements for the newly created Remote Monitoring CPT Code, as defined by Centers of Medicare and Medicaid Services (CMS). The iGlucose solution, which uses cell-enabled technology to automatically transmit real-time blood glucose results, is providing clinicians with another tool for making connected health more available and more widely
Read More
Livongo Health Acquires Disease Prevention Startup Retrofit
Livongo Health, a consumer digital health company that is empowering people with chronic diseases to live better has acquired Retrofit, a provider of innovative weight-management and disease-prevention programs that transform lives, workplaces and communities. The acquisition provides Livongo with a proven, evidence-based, Diabetes Prevention Program, enhances its data science capabilities, and boosts expertise in holistic weight management, including nutrition, exercise and mindset."Retrofit
Read More
Common Sensing Raises $6.6M to Scale Smart Insulin Pen Cap
Common Sensing, an evidence-based, data-driven injectable-medicine startup has raised $6.6 million in Series A funding led by Waterline Ventures. New World Health and Royal Philips with participation from Haselmeier. The Cambridge, MA-based digital health startup plans to use the funds to accelerate Common Sensing's manufacturing and commercial operations for its smart insulin pen cap solution, Gocap. The IP-protected dose monitoring solution enables patients and providers to better utilize
Read More
Livongo Health Raises $105M for Mobile Diabetes Management, Inks Deal with Cambia Health
Livongo Health, a consumer digital health company that is empowering people with chronic diseases to live better has raised $105 million in funding led by existing investors General Catalyst and international investment company Kinnevik. Existing investors DFJ, Kleiner Perkins Caufield & Byers , Merck Global Health Innovation Fund, Microsoft Ventures, Sapphire Ventures, Zaffre Investments, and 7wire Ventures participated in the round along with new investor Echo Health Ventures.Livongo
Read More
Vitra Health Nabs $45M to Reverse Type 2 Diabetes
Virta Health, a San Francisco, CA-based company delivering the first clinically-proven treatment to safely and sustainably reverse type 2 diabetes (T2D) and other chronic metabolic diseases without the use of medications or surgery has raised a $45 million Series B funding round. THe round include participation from existing investors including Venrock, Obvious Ventures, Creandum,Caffeinated Capital, and Max Levchin’s SciFi VC, along with new investors including Founders Fund and Playground
Read More
Providence Health & Services Launches Digital Therapeutic Pilot Program for Individuals with Type 2 Diabetes
WellDoc announced a pilot program with Providence Health & Services to examine the use of WellDoc’s BlueStar, an FDA-cleared, proven digital therapeutic for individuals with type 2 diabetes. Providence Health & Services has utilized the power and innovation of mobile technology into clinical practice before and is now carrying it into the diabetes management arena.The pilot program will take place in the Providence Health & Services Oregon/SW Washington Region. It will include
Read More
Research: How Personality Affects Gamified Diabetes Self-Management
Personality differences might explain why mobile health apps for self-managing diabetes help some patients more than others, according to researchers at the University of Maryland. UMD researchers. Mobile health apps using gamified elements, like Empower by Ayogo and Fitocracy, for improving behaviors important to self-managing chronic illness are growing in popularity. However, evidence of effectiveness of mobile health apps has been mixed. Meanwhile, rates of Type 2 diabetes in older adults
Read More